SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Eiger BioPharmaceuticals Q1 EPS $(0.620) Up From $(0.900) YoY

Eiger BioPharmaceuticals (NASDAQ:EIGR) reported quarterly losses of $(0.620) per share. This is a 31.11 percent increase over losses of $(0.900) per share from the same period last year.

Benzinga · 05/07/2020 20:39

Eiger BioPharmaceuticals (NASDAQ:EIGR) reported quarterly losses of $(0.620) per share. This is a 31.11 percent increase over losses of $(0.900) per share from the same period last year.